Insiders · ZYNE

ZYNE insider transactions

Zynerba Pharmaceuticals Inc. (ZYNE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ZYNE

• 972d
  Jones Kenneth T was granted 30,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Stephenson Pamela closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Fickenscher James E was granted 170,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Sebree Terri B was granted 170,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Federici William J closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Rosenberger Brian was granted 120,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Cooper Warren D closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Parker Albert P was granted 85,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Butler John P. closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Moch Kenneth I closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Anido Armando was granted 240,000 shares, closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 972d
  Kisner Daniel L closing all direct ownership in the company (SEC Form 4)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 998d
  SEC Form 4: Sebree Terri B was granted 45,000 shares and sold $16,440 worth of shares (12,401 units at $1.33), increasing direct ownership by 6% to 596,241 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 998d
  SEC Form 4: Rosenberger Brian was granted 22,200 shares and sold $8,499 worth of shares (6,411 units at $1.33), increasing direct ownership by 7% to 249,559 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 998d
  SEC Form 4: Fickenscher James E was granted 31,200 shares and sold $11,929 worth of shares (8,998 units at $1.33), increasing direct ownership by 6% to 378,087 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 998d
  SEC Form 4: Jones Kenneth T was granted 9,000 shares and sold $3,321 worth of shares (2,505 units at $1.33), increasing direct ownership by 8% to 85,520 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 998d
  SEC Form 4: Anido Armando was granted 64,747 shares and sold $23,637 worth of shares (17,830 units at $1.33), increasing direct ownership by 5% to 936,722 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1028d
  SEC Form 3: New insider Jones Kenneth T claimed ownership of 79,025 shares

  3 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1089d
  SEC Form 4 filed by Stephenson Pamela

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1089d
  SEC Form 4 filed by Moch Kenneth I

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1089d
  SEC Form 4 filed by Kisner Daniel L

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1089d
  SEC Form 4 filed by Federici William J

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1089d
  SEC Form 4 filed by Cooper Warren D

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1089d
  SEC Form 4 filed by Butler John P.

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1207d
  SEC Form 4: Parker Albert P sold $1,719 worth of shares (3,173 units at $0.54), decreasing direct ownership by 1% to 227,018 units (tax liability)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1215d
  SEC Form 4: Rosenberger Brian was granted 14,926 shares and covered exercise/tax liability with 5,145 shares, increasing direct ownership by 4% to 233,770 units (for withholding tax)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1215d
  SEC Form 4: Sebree Terri B was granted 36,044 shares and covered exercise/tax liability with 9,973 shares, increasing direct ownership by 5% to 563,642 units (withholding obligation)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1215d
  SEC Form 4: Fickenscher James E was granted 22,547 shares and covered exercise/tax liability with 6,544 shares, increasing direct ownership by 5% to 355,885 units (for withholding tax)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1215d
  SEC Form 4: Anido Armando was granted 45,406 shares and covered exercise/tax liability with 12,547 shares, increasing direct ownership by 4% to 889,805 units to satisfy withholding tax

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1215d
  SEC Form 4: Parker Albert P was granted 18,864 shares and covered exercise/tax liability with 5,463 shares, increasing direct ownership by 6% to 230,191 units to satisfy withholding tax

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1222d
  SEC Form 4: Anido Armando was granted 42,437 shares and covered exercise/tax liability with 11,726 shares, increasing direct ownership by 4% to 856,946 units (for withholding tax)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1222d
  SEC Form 4: Parker Albert P was granted 17,631 shares and covered exercise/tax liability with 5,841 shares, increasing direct ownership by 6% to 216,790 units to satisfy tax liability

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1222d
  SEC Form 4: Rosenberger Brian was granted 13,950 shares and covered exercise/tax liability with 4,809 shares, increasing direct ownership by 4% to 223,989 units to satisfy withholding tax

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1222d
  SEC Form 4: Fickenscher James E covered exercise/tax liability with 5,927 shares and was granted 21,073 shares, increasing direct ownership by 5% to 339,882 units to satisfy withholding tax

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1222d
  SEC Form 4: Sebree Terri B was granted 33,688 shares and covered exercise/tax liability with 9,321 shares, increasing direct ownership by 5% to 537,571 units (withholding tax)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1230d
  SEC Form 4: Parker Albert P was granted 170,000 shares, increasing direct ownership by 486% to 205,000 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1230d
  SEC Form 4: Sebree Terri B sold $14,742 worth of shares (24,661 units at $0.60) and was granted 170,000 shares, increasing direct ownership by 40% to 513,204 units (withholding obligation)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1230d
  SEC Form 4: Fickenscher James E sold $10,622 worth of shares (17,769 units at $0.60) and was granted 170,000 shares, increasing direct ownership by 88% to 324,736 units to satisfy tax liability

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1230d
  SEC Form 4: Rosenberger Brian sold $7,570 worth of shares (12,663 units at $0.60) and was granted 120,000 shares, increasing direct ownership by 100% to 214,848 units to satisfy withholding tax

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1230d
  SEC Form 4: Anido Armando sold $21,194 worth of shares (35,453 units at $0.60) and was granted 250,000 shares, increasing direct ownership by 35% to 826,235 units (withholding tax)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1419d
  SEC Form 4: Sebree Terri B was granted 30,000 shares and sold $9,109 worth of shares (8,281 units at $1.10), increasing direct ownership by 6% to 367,865 units (withholding obligation)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1419d
  SEC Form 4: Rosenberger Brian was granted 14,800 shares and sold $4,718 worth of shares (4,289 units at $1.10), increasing direct ownership by 11% to 107,511 units (withholding obligation)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1419d
  SEC Form 4: Anido Armando was granted 43,164 shares and sold $13,089 worth of shares (11,899 units at $1.10), increasing direct ownership by 5% to 611,688 units (for withholding tax)

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1419d
  SEC Form 4: Fickenscher James E was granted 20,800 shares and sold $6,614 worth of shares (6,013 units at $1.10), increasing direct ownership by 9% to 172,505 units to cover taxes

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1453d
  SEC Form 4: Kisner Daniel L was granted 23,109 shares and sold $40 worth of shares (40 units at $1.01), increasing direct ownership by 461% to 28,069 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1453d
  SEC Form 4: Federici William J was granted 23,109 shares and sold $40 worth of shares (40 units at $1.01), increasing direct ownership by 461% to 28,069 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1453d
  SEC Form 4: Stephenson Pamela was granted 23,109 shares and sold $40 worth of shares (40 units at $1.01), increasing direct ownership by 461% to 28,069 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1453d
  SEC Form 4: Moch Kenneth I was granted 23,109 shares and sold $40 worth of shares (40 units at $1.01), increasing direct ownership by 461% to 28,069 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1453d
  SEC Form 4: Cooper Warren D was granted 23,109 shares and sold $40 worth of shares (40 units at $1.01), increasing direct ownership by 461% to 28,069 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1453d
  SEC Form 4: Butler John P. was granted 23,109 shares and sold $54 worth of shares (53 units at $1.01), increasing direct ownership by 231% to 33,056 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1574d
  SEC Form 3 filed by new insider Parker Albert P

  3 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1574d
  SEC Form 4: Parker Albert P was granted 35,000 shares

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1592d
  SEC Form 4: Anido Armando was granted 120,000 shares, increasing direct ownership by 26% to 580,423 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1592d
  SEC Form 4: Fickenscher James E was granted 85,000 shares, increasing direct ownership by 117% to 157,718 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1592d
  SEC Form 4: Rosenberger Brian was granted 60,000 shares, increasing direct ownership by 162% to 97,000 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1592d
  SEC Form 4: Sebree Terri B was granted 85,000 shares, increasing direct ownership by 33% to 346,146 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1768d
  SEC Form 4: Butler John P. was granted 5,000 units of Common Stock, increasing direct ownership by 100% to 10,000 units

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1768d
  SEC Form 4: Stephenson Pamela was granted 5,000 units of Common Stock

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1768d
  SEC Form 4: COOPER WARREN D was granted 5,000 units of Common Stock

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)
• 1768d
  SEC Form 4 filed by Zynerba Pharmaceuticals, Inc.

  4 - Zynerba Pharmaceuticals, Inc. (0001621443) (Issuer)